Microarrays in genomics Flashcards

1
Q

What is a constitutional genetic disorder? (2)

A
  • Genetic aberrations which are present in all cells from birth (also called germline)
  • Somatic genetic aberrations are acquired later in life and are mosaic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the resolution of karyotyping?

A

5-20 megabase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the principle of karyotyping? (3)

A
  • Trypsin digestion produces light and dark bands
  • Dark = AT rich, heterochromatin
  • Light = GC rich, euchromatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does FISH work? (6)

A
  • ssDNA probe complimentary to target sequence is fluorescently labelled
  • Denature the chromosomes to allow the probe to access the target sequence
  • Hybridise
  • Wash to remove background signal
  • Apply DAPI to visualise chromosomes
  • Analyse with fluorescent microscope
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the types of FISH probe? (2)

A
  • Whole chromosome paint
  • Locus specific probe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What can FISH show? (3)

A
  • Gene amplification
  • Translocations
  • Gene fusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a microarray? (5)

A
  • A set of DNA probes are attached on an array (slide)
  • Assay uses fluorescently labelled patient DNA to bind to the probes
  • Compare with relative quantity of control DNA to identify gain and loss of chromosomal material
  • Gains and losses = copy number variants
  • Use software to identify the genomic location of the CNVs and which genes are involved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the benefit of karyotyping over microarrays?

A

Microarrays can’t detect genetically balanced rearrangements e.g. translocations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which patients are tested using microarrays? (3)

A
  • Children with developmental delay (autism, intellectual disability, dysmorphic features, congenital abnormalities)
  • Prenatal analysis (DNA from amniotic fluid/CVS, abnormal ultrasound scans)
  • Cancer (e.g. myeloid dysplastic syndrome loss of 5q)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the benefits of microarrays over karyotyping? (3)

A
  • Microarrays have increased sensitivity: karyotyping can only detect gains and losses of 5-10 megabases, microarrays can detect gains and losses of 100 kilobases
  • Karyotype of children with developmental delay has a diagnosis rate of 5% but testing the same children with microarrays has diagnosis rate of 20%
  • Higher sensitivity = more diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 2 main types of microarrays?

A
  • Oligonucleotide arrays
  • Single nucleotide polymorphism (SNP) arrays
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are oligonucleotide arrays?

A

Uses oligonucleotide DNA probes that are complimentary to specific regions of the genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are SNP arrays?

A

Uses 100 000s of SNP probes across the genome to measure the ratio of one allele vs another by targeting the normal variant within the human genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do oligonucleotide arrays work? (7)

A
  • DNA is fragmented
  • Patient and control DNA have different fluorescent labels
  • Competitive hybridisation to the oligonucleotides on the slide
  • The amount of bound patient vs control DNA is measured by relative fluorescence intensity
  • If patient and control is the same amount, relative fluorescence will be 1:1
  • If patient has stronger fluorescence (1:2) this means the patient has a gain of genetic material at the location the oligo probe is specific for
  • If the patient has weaker fluorescence (2:1), the patient has lost genetic material at this location
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do oligonucleotide arrays detect? (2)

A
  • Copy number variants (CNVs)
  • Do not detect genetically balanced rearrangements e.g. translocations and inversions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When are apparent losses/gains significant on an oligonucleotide array profile? (2)

A
  • At least 3 neighbouring probes showing a loss or gain
  • Single calls are likely to be artefacts
17
Q

What is an SNP? (6)

A
  • Single nucleotide polymorphism
  • A change in a single nucleotide in the DNA sequence of the human genome
  • Not mutations, normal variants
  • Approximately 10 million SNPs in the genome
  • In a given location where there is a SNP there are 2 allele types: one with SNP and one WT referred to as A and B
  • Individual can be WT for both alleles or have SNP in both or heterozygous (AA, BB, AB, BA)
18
Q

How do SNP arrays work? (9)

A
  • Only patient DNA required, no control
  • Contains DNA probes for WT and known SNPs
  • Each allele (A and B) are represented on the array
  • SNP A and B probes are differently fluorescently labelled red or green
  • Amplify and fragment patient DNA, hybridise
  • Patient DNA binds the probes = fluorescence emitted and detected by scanner
  • Both probes emit fluorescence = heterozygous, one = homozygous
  • Can also identify gains/losses
  • Patient may be AA, BB or AB
19
Q

What is loss of heterozygosity? (4)

A
  • Can be detected by SNP array
  • Loss of small or large chromosomal region resulting in no heterozygous SNPs
  • Can imply that the individuals’ parents are related as it shows there is less normal variation in their genotype
  • LoH can unmask recessive mutations that may cause disease
20
Q

How do you interpret the data from SNP array? (5)

A
  • Middle band = AB heterozygous, 1:1 fluorescence
  • Top band = AA homozygous, 1
  • Bottom band = BB homozygous, 0
  • SNPs are plotted in order along each chromosome
  • Gap in the middle = centromere
21
Q

What does a deletion look like on a SNP array? (3)

A
  • Deletion means only one allele so there can only be an A allele or a B allele, can’t be a AB heterozygous genotype
  • Large run of homozygosity indicates a deletion
  • Would need to see many areas of homozygosity to consider LoH
22
Q

What does a duplication look like on a SNP array? (3)

A
  • 2 bands in the middle rather than 1 because each SNP will either be AAA, BBB, AAB or ABB (depending which is duplicated) but no AB
  • 4 regions of calls with different relative fluorescence
  • Seen in trisomy
23
Q

What is Pallister-Killian syndrome? (7)

A
  • Characterised by mosaic tetrasomy isochromosome 12p
  • Never seen in blood karyotype, can be seen in skin cell karyotype
  • Non-mosaic isochromosome 12p is lethal
  • Developmental delay and intellectual disability
  • Extra digits
  • Characteristic facial features
  • Hypotonia
24
Q

Is a gain or loss more likely to have a phenotypic consequence?

A

Loss because the absence of a protein is more significant than having too much of a protein (deletion is a more common mechanism of disease)

25
Q

How should a CNV be assessed? (6)

A
  • Size isn’t a reliable indicator of predicting normal gain/loss or pathogenic gain/loss because normal CNVs can be very small or very large
  • Consider whether any genes are involved: may not contain any genes (unlikely to be pathogenic), may contain a gene associated with a genetic disorder
  • Consider location: the gain/loss location may be associated with a particular genomic syndrome
  • Do the genes affected by the CNV fit with the referral reason
  • Is the CNV present in the normal population (if the CNV is in more than 1% of the population we can dismiss it as disease causing)
  • Do the parents have the same change (parent is fine and has the CNV = less likely to be causative, consider penetrance)
26
Q

What is Di George syndrome?

A

Caused by deletion of the TBX1 gene at 22q11.2

27
Q

What are incidental findings? (2)

A
  • A genetic problem that you aren’t looking for but couldn’t avoid finding
  • Unexpected and unrelated to the referral reason, may have severe implications for the patient and relatives
28
Q

What is penetrance? (3)

A
  • A measure of the likelihood of a genetic variant causing a disease
  • A variant/CNV doesn’t always cause medical problems
  • Expressed as a percentage of times a variant would be expected to cause a disease (100% penetrance = 100% of people with the variant have the disease)
29
Q

What does genome sequencing achieve? (4)

A
  • Detect single nucleotide DNA variants
  • With bioinformatics can detect copy number and balanced rearrangements
  • Mosaicism is dependent on depth of coverage
  • But generates lots of data
30
Q

What does karyotype and FISH achieve? (3)

A
  • Large abnormalities
  • Balanced rearrangements
  • 10% mosaicism detection
31
Q

What do microarrays achieve? (3)

A
  • Smaller abnormalities than karyotype and FISH because more sensitive
  • Can’t detect balanced changes
  • 10-30% mosaicism detection
32
Q

What is quantitative fluorescent PCR used for? (3)

A
  • Detecting aneuploidy in prenatal testing of amniotic fluid and chorionic villus samples at risk of Down syndrome (copy number assay)
  • Urgent 24 hour test
  • Amplifies and quantifies at the same time
33
Q

How does QF-PCR work? (7)

A
  • Uses fluorescently labelled PCR primers which are targeted to amplify small tandem repeats (STRs)
  • STRs are repeats of two or more nucleotides, number of repeats varies between people, for an STR on chromosome 21 one allele may have 5 repeats the other allele may have 9
  • Both alleles are amplified
  • Disomic (no gain): both alleles should amplify to the same degree so same number of DNA fragments for each allele
  • Relative copy number is measured by fluorescence intensity
  • Disomic: 2 peaks of similar size (1:1)
  • Trisomy: 3 peaks (1:1:1) each with different size STRs or 2 peaks (2:1) if 2 alleles have same STR size
34
Q

What is digital droplet PCR? (7)

A
  • Used to test for a specific DNA variant to a higher resolution (e.g. if only present in 1 out of 20 000 cells) to identify low level mosaicism
  • Separate patient DNA into separate droplets and do PCR reactions
  • A portion of the droplets will contain the variant of interest and a portion are wildtype
  • If patient is heterozygous, 50% of droplets will have the variant of interest
  • 2 DNA probes are used (WT or variant) with a fluorescent marker and quencher molecule (which prevents fluorescence)
  • If probe binds, quencher is separated so the fluorescence is emitted and registered by scanner so each droplet is positive for variant or WT fluorescence
  • Single cell analysis but look at 1000s of cells
35
Q

How do you interpret ddPCR output? (3)

A
  • Four clusters of droplets
  • Double negative (no targeted DNA templates), WT only, mutant only, double positive (contain both WT and mutant templates)
  • Can see proportion of cells with the variant so good technique for exclusion and measurement of mosaicism